Dr. William Young, MD

NPI: 1376649202
Total Payments
$5,910
2024 Payments
$193.23
Companies
22
Transactions
337
Medicare Patients
8,817
Medicare Billing
$484,882

Payment Breakdown by Category

Food & Beverage$5,851 (99.0%)
Education$58.41 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,851 330 99.0%
Education $58.41 7 1.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,479 82 $0 (2024)
Novo Nordisk Inc $1,081 53 $0 (2024)
GlaxoSmithKline, LLC. $525.01 35 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $494.82 20 $0 (2024)
Amarin Pharma Inc. $423.27 28 $0 (2022)
Esperion Therapeutics, Inc. $339.84 14 $0 (2024)
Janssen Pharmaceuticals, Inc $285.29 19 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $237.20 15 $0 (2023)
PFIZER INC. $232.68 17 $0 (2023)
Amgen Inc. $179.42 11 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $193.23 11 GlaxoSmithKline, LLC. ($45.35)
2023 $307.93 16 GlaxoSmithKline, LLC. ($97.04)
2022 $907.14 44 Bayer HealthCare Pharmaceuticals Inc. ($374.82)
2021 $1,312 62 AstraZeneca Pharmaceuticals LP ($342.33)
2020 $915.46 56 AstraZeneca Pharmaceuticals LP ($335.91)
2019 $609.86 41 AstraZeneca Pharmaceuticals LP ($187.99)
2018 $983.84 59 AstraZeneca Pharmaceuticals LP ($300.50)
2017 $679.61 48 AstraZeneca Pharmaceuticals LP ($192.19)

All Payment Transactions

337 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
10/02/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.34 General
Category: RESPIRATORY
10/01/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.62 General
Category: Diabetes
07/01/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.59 General
Category: RESPIRATORY
05/15/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.11 General
Category: Cardiovascular and Metabolism
04/30/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.38 General
Category: Cardio-renal
04/05/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $25.97 General
Category: Diabetes
03/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.50 General
Category: Diabetes
03/11/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $17.39 General
Category: ANTILIPEMIC AGENTS
02/21/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.40 General
Category: Respiratory
01/31/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.51 General
Category: Cardio-renal
01/30/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.42 General
Category: RESPIRATORY
12/28/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $20.12 General
Category: RESPIRATORY
12/11/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Cardio-renal
12/05/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.77 General
Category: DIABETES
11/29/2023 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.29 General
Category: Respiratory
11/28/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.02 General
Category: Diabetes
10/17/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $23.84 General
Category: RESPIRATORY
08/28/2023 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.39 General
Category: Diabetes
06/23/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $26.30 General
Category: RESPIRATORY
06/13/2023 Azurity Pharmaceuticals, Inc. Edarbi (Drug) Food and Beverage Cash or cash equivalent $19.38 General
Category: Cardiology/Vascular Diseases
05/26/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.63 General
Category: Cardio-renal
05/10/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $27.34 General
Category: Cardio-renal
04/10/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $26.78 General
Category: RESPIRATORY
04/10/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $13.15 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/04/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $12.89 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 26 2,010 3,565 $157,394 $103,116
2022 25 2,180 3,773 $186,912 $119,763
2021 24 2,233 3,979 $197,285 $129,333
2020 27 2,394 4,341 $206,603 $132,671
Total Patients
8,817
Total Services
15,658
Medicare Billing
$484,882
Procedure Codes
102

All Medicare Procedures & Services

102 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 171 626 $84,510 $52,044 61.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 119 119 $16,065 $14,962 93.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 23 37 $8,325 $4,862 58.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 13 56 $5,880 $3,506 59.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 20 35 $4,375 $3,296 75.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 23 33 $4,125 $2,950 71.5%
71046 X-ray of chest, 2 views Office 2023 129 138 $6,900 $2,949 42.7%
83721 Ldl cholesterol level Office 2023 144 278 $3,336 $2,861 85.8%
36415 Insertion of needle into vein for collection of blood sample Office 2023 160 594 $2,376 $2,328 98.0%
84478 Triglycerides level Office 2023 143 276 $1,656 $1,554 93.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $2,450 $1,483 60.5%
80053 Blood test, comprehensive group of blood chemicals Office 2023 120 121 $2,057 $1,252 60.9%
80076 Liver function blood test panel Office 2023 108 143 $1,859 $1,145 61.6%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 117 142 $1,846 $1,081 58.5%
80048 Blood test, basic group of blood chemicals (calcium, total) Office 2023 71 127 $1,905 $1,053 55.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 107 112 $3,024 $1,020 33.7%
80069 Kidney function blood test panel Office 2023 94 103 $1,442 $876.53 60.8%
81002 Urinalysis, manual test Office 2023 140 233 $932.00 $794.53 85.2%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 39 39 $780.00 $690.30 88.5%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 37 37 $740.00 $654.90 88.5%
82044 Urine microalbumin (protein) analysis Office 2023 62 72 $576.00 $439.92 76.4%
82950 Blood glucose (sugar) level after receiving dose of glucose Office 2023 36 92 $736.00 $427.80 58.1%
82570 Creatinine level to test for kidney function or muscle injury Office 2023 61 70 $560.00 $355.60 63.5%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2023 22 23 $460.00 $301.76 65.6%
82947 Blood glucose (sugar) level Office 2023 26 34 $204.00 $130.90 64.2%

About Dr. William Young, MD

Dr. William Young, MD is a Family Medicine healthcare provider based in Spring Hill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376649202.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Young, MD has received a total of $5,910 in payments from pharmaceutical and medical device companies, with $193.23 received in 2024. These payments were reported across 337 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,851).

As a Medicare-enrolled provider, Young has provided services to 8,817 Medicare beneficiaries, totaling 15,658 services with total Medicare billing of $484,882. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Spring Hill, FL
  • Active Since 09/16/2006
  • Last Updated 01/17/2008
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1376649202

Products in Payments

  • FARXIGA (Drug) $1,014
  • Ozempic (Drug) $499.51
  • Kerendia (Drug) $494.82
  • TRELEGY ELLIPTA (Drug) $425.05
  • Vascepa (Drug) $423.27
  • BEVESPI AEROSPHERE (Drug) $269.00
  • JARDIANCE (Drug) $226.82
  • ELIQUIS (Drug) $215.55
  • NEXLETOL (Drug) $214.84
  • XARELTO (Drug) $200.75
  • Victoza (Drug) $156.47
  • RYBELSUS (Drug) $137.88
  • Rybelsus (Drug) $130.72
  • Tresiba (Drug) $129.74
  • NEXLIZET (Drug) $125.00
  • JANUVIA (Drug) $124.43
  • EVENITY (Biological) $102.51
  • BREZTRI (Drug) $95.80
  • Edarbi (Drug) $95.55
  • INVOKANA (Drug) $84.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Spring Hill